NCT02601885 - A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 18, 2016

Primary Completion Date

April 20, 2018

Study Completion Date

April 20, 2018

Conditions

Multiple Sclerosis

Interventions

DRUG

ABT-555

Intravenous Infusion

OTHER

Placebo

Intravenous Infusion

Trial Locations (8)

Parexel International, Baltimore

Integrated Neurology Services, Alexandria

Duke Univ Med Ctr, Durham

Compass Research LLC, Orlando

Tri-State Mountain Neurology, Johnson City

MIND, Farmington Hills

Rowe Neurology Institute, Lenexa

Clinical Trial Network, Houston